| mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
2e-06 |
| mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
7e-05 |
| mRNA |
VX-11e |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0005 |
| mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.002 |
| mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
| mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.002 |
| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
| mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.005 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.006 |